Recently, research demonstrated that TRIM38 interacts with GLUT1 to suppress the progression of bladder cancer,[33] and another study revealed that TRIM38 regulates the AMPK/NF‐κB/NLRP3 pathway to inhibit the progression of lung cancer,[34] gradually revealing the importance of TRIM38 in malignancy. Here, SLC2A1 is linked to urinary bladder carcinoma.